Subjective and Objective Performance With the SONNET2EAS
Withdrawn before enrolling · Not applicable
Conditions studied: Hearing Loss, Hearing Disability
In brief
Purpose: The purpose of this study is to demonstrate the non-inferiority and new features of an external speech processor for cochlear implant recipients. Participants: This study seeks to enroll 15 cochlear implant recipients listening to previous technology. Procedures (methods): Subjects will be programmed and tested with old and new technology.
Key facts
- Study ID
- NCT04721990
- Run by
- University of North Carolina, Chapel Hill
- People needed
- 0
- Starts
- 2021-04-01
- Expected to finish
- 2023-04-01
- Last updated by the study team
- 2021-08-18
Who can join
Age: 18 and older, up to 99. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Adult (≥18 years at date of enrollment/initial evaluation)
- MED-EL Cochlear Implant System recipient
- Unilateral cochlear implant recipient
- Unaided threshold of ≤65 decibels (dB) Hearing Level (HL) at 125 Hz in implanted ear
- Six months or greater of SONNETEAS listening experience
- Consistent device user, as deemed by research team
- Minimum of 10 enabled electrodes
- Consonant Nucleus Consonant (CNC) word score of ≥40% with SONNETEAS processor and contralateral ear plugged/masked
- Native English speaker (as all materials are written or spoken in English)
You may not qualify if…
- Unaided pure tone average (500, 1000, 2000 Hz) ≤60 dB HL in the contralateral (non-implanted) ear
- Hearing technology other than a conventional hearing aid in the contralateral ear
- Unwilling, unable, or geographic limitations to participate in study procedures
- Unwilling to complete datalogging with the processor
Where it is running
- University of North Carolina at Chapel Hill — Chapel Hill, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.